Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05532670 · ClinicalTrials.gov registry record
N600X Low Saturation Accuracy Validation
A clinical trial, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 15
- Enrollment target
NCT05532670: Completed study, sponsored by Medtronic - MITG.
NCT05532670 is a clinical trial that has completed, run by Medtronic - MITG. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05532670 has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
To compare pulse oximetry saturation measurements, during normal to low saturation, to saturation measurements made by a multi-wavelength CO-oximeter, taken from arterial blood samples from healthy human subjects.
Primary Outcome
To validate the proposed claims for pulse rate (BPM) accuracy in diverse subject population during Low Saturation over a specified saturation ranges.
Interventions
- DEVICE Non-Invasive Controlled Hypoxia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-09-29 |
| Est. Completion | 2022-11-01 |
What the finished NCT05532670 record still lists
NCT05532670 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Non-Invasive Controlled Hypoxia is the first listed.
NCT05532670 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05532670 about?
NCT05532670 is a clinical study titled "N600X Low Saturation Accuracy Validation". To compare pulse oximetry saturation measurements, during normal to low saturation, to saturation measurements made by a multi-wavelength CO-oximeter, taken from arterial blood samples from healthy human subjects.
What is the current status of trial NCT05532670?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2022-09-29. Estimated completion is 2022-11-01.
What interventions are being tested in trial NCT05532670?
The interventions under investigation include: Non-Invasive Controlled Hypoxia (DEVICE).
Who is sponsoring clinical trial NCT05532670?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI